Emerging avenues linking myeloid-derived suppressor cells to periodontal disease

Int Rev Cell Mol Biol. 2023:375:165-189. doi: 10.1016/bs.ircmb.2022.12.001. Epub 2023 Jan 11.

Abstract

Periodontal disease is one of the most common inflammatory disorders in humans. Gingivitis is the mildest form of periodontal disease and its progression can lead to periodontitis, an inflammatory disease characterized by soft tissue damage that can lead to progressive destruction of the periodontal ligament and alveolar bone. Diverse populations of immune cells are involved in periodontal disease. Myeloid-derived suppressor cells (MDSCs) represent a heterogeneous group of immature myeloid cells derived from hematopoietic precursor cells and exhibit T cell immunosuppressive functions that are thought to be involved in periodontal disease. Therefore, MDSCs have been recently analyzed in the context of this disease. In this review, we discuss the most recent advances in the characterization of the biological aspects, subpopulations, and traffic of MDSCs, as well as their immunosuppressive and osteoclastogenic activity in the context of periodontal disease and in the presence of key periodontal pathogens.

Keywords: MDSC; Oral bacteria; Periodontal disease; Periodontium.

Publication types

  • Review

MeSH terms

  • Humans
  • Immunosuppressive Agents
  • Myeloid-Derived Suppressor Cells*
  • Periodontal Diseases*

Substances

  • Immunosuppressive Agents